539470 — Shree Ganesh Bio-Tech (India) Balance Sheet
0.000.00%
- IN₹294.98m
- IN₹294.85m
- IN₹229.58m
- 65
- 38
- 26
- 36
Annual balance sheet for Shree Ganesh Bio-Tech (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.242 | 0.352 | 4.8 | 4.28 | 0.131 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 283 | 439 | 194 | 33 | 0 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 284 | 440 | 198 | 37.3 | 33.9 |
| Net Property, Plant And Equipment | 0.04 | 0.035 | 0.029 | 0.024 | 0.019 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 746 | 936 | 795 | 736 | 635 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 166 | 332 | 172 | 106 | 2.32 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 168 | 332 | 172 | 106 | 2.32 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 578 | 603 | 624 | 630 | 633 |
| Total Liabilities & Shareholders' Equity | 746 | 936 | 795 | 736 | 635 |
| Total Common Shares Outstanding |